Axsome Therapeutics, Inc. (0HKF.L) LSE

155.62

+0.37(+0.24%)

Updated at December 24 02:59PM

Currency In USD

Valuation

Market Cap4.05B
Enterprise Value3.93B
P/E Ratio-33.48
PEG Ratio-4.24
Price/Sales Ratio13.8
Price/Book Ratio104.24
Enterprise/Revenue13.61
Enterprise/EBITDA-35.32

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.41
Operating Margin-0.38

Management Effectiveness

Return On Assets-0.34
Return On Equity-3.57

Income Statement

Revenue385.69M
Revenue/Share11.22
Gross Profit352.39M
EBITDA-272.6M
Net Income-287.22M
Diluted EPS-5.99

Balance Sheet

Total Cash325.27M
Total Cash/Share6.5
Total Debt218.6M
Total Debt/Equity2.93
Current Ratio1.57
Book Value Per Share1.47

Price History

52-Week Change79.18
52-Week High155.62
52-Week Low55.64
Moving Average 50 Days85.35
Moving Average 200 Days75.3

Statistics

Average Volume562
Shares Outstanding49.22M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A